Mequinol
![]() | |
| Clinical data | |
|---|---|
| Synonyms | 4-Hydroxyanisole; para-Guaiacol |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a682437 |
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C7H8O2 |
| Molar mass | 124.13722 g/mol |
| Density | 1.55 g/cm3 |
| Melting point | 52.5 °C (126.5 °F) |
| Boiling point | 243 °C (469.4 °F) |
| |
| (verify) | |
|
WikiDoc Resources for Mequinol |
|
Articles |
|---|
|
Most recent articles on Mequinol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Mequinol at Clinical Trials.gov Clinical Trials on Mequinol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Mequinol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Mequinol Risk calculators and risk factors for Mequinol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Mequinol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mequinol, or 4-Methoxyphenol, is a phenol used in dermatology[1] and organic chemistry.[2]
Uses
Dermatology
Mequinol is a common active ingredient in topical drugs used for skin depigmentation. As a topical drug Mequinol is often mixed with tretinoin, a topical retinoid. A common formulation for this drug is an ethanolic solution of 2% Mequinol and 0.01% tretinoin by mass.[1] Dermatologists commonly prescribe the drug to treat solar lentigines, liver spots, or age spots.
Lower dosages of mequinol have been used in conjunction with a Q-switched laser to depigment skin in patients with disseminated idiopathic vitiligo.[3]
Organic chemistry
In organic chemistry 4-Methoxyphenol is used to inhibit the radical polymerization of monomers (e.g. acrylates or styrene monomers).[2]
Preparation
4-Methoxyphenol is produced from p-benzoquinone and methanol via a free radical reaction.[4][5]
See also
- Monobenzone (benzyloxyphenol)
- Hydroquinone
- Guaiacol
References
- ↑ 1.0 1.1 Stiefel Laboratories, Inc. "Full Prescribing Information" (PDF). US Food and Drug Admistration. Retrieved 2 January 2015.
- ↑ 2.0 2.1 Hudnall, Phillip M. (2000). "Hydroquinone". Ullmann's Encyclopedia of Industrial Chemistry. doi:10.1002/14356007.a13_499.
- ↑ Komen, L.; Zwertbroek, L.; Burger, S.J.; van der Veen, J.P.W.; de Rie, M.A.; Wolkerstorfer, A. (2013). "Q-switched laser depigmentation in vitiligo, most effective in active disease". British Journal of Dermatology. 169 (6): 1246–1251. doi:10.1111/bjd.12571.
- ↑ Cristian, Gambarotti; Lucio, Melone; Carlo, Punta; Suresh Udhavrao, Shisodia (2013). "Selective Monoetherification of 1,4-Hydroquinone Promoted by NaNO2". Current Organic Chemistry. 17 (10): 1108–1113.
- ↑ Correale, Mariano; Panseri, Pietro; Romano, Ugo; Minisci, Francesco. "Process for the preparation of mono-ethers of hydroquinones US4933504A". Google Patents. Enichem Synthesis S.P.A. Retrieved 2 January 2015.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to watched fields
- Drug
- Phenols
- Phenol ethers
